Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor. (2012)
Attributed to:
Rational design and biological evaluation of cell-permeant small molecule agonists and antagonists of the NAADP receptor
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/jm300671m
PubMed Identifier: 22793499
Publication URI: http://europepmc.org/abstract/MED/22793499
Type: Journal Article/Review
Volume: 55
Parent Publication: Journal of medicinal chemistry
Issue: 16
ISSN: 0022-2623